Difference between revisions of "Part:BBa K3140002"

Line 159: Line 159:
 
The ''in vivo'' activity of PsiK is confirmed by observation of PsiK product norbaeocystin ('''Fig. 7''').
 
The ''in vivo'' activity of PsiK is confirmed by observation of PsiK product norbaeocystin ('''Fig. 7''').
  
[[Image:T--Sydney_Australia--tryptamine16_387_lcms.png|frame|none|'''Fig. 7''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.]]
+
[[Image:T--Sydney_Australia--norbaeo16_387_lcms.png|frame|none|'''Fig. 7''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 257.06857 with chemical formula C10H14N2O4P was identified, matching PsiK product norbaeocystin.]]
  
Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from ''Psilocybe cubensis'' in ''Escherichia coli'' both ''in vivo'' and ''in vitro''.
+
Given these results, we conclude that we have successfully expressed the 4-hydroxytryptamine kinase decarboxylase PsiK from ''Psilocybe cubensis'' in ''Escherichia coli'' both ''in vivo'' and ''in vitro''.
  
 
<span class='h3bb'>'''Sequence and Features'''</span>
 
<span class='h3bb'>'''Sequence and Features'''</span>

Revision as of 05:04, 20 October 2019


PsiK - 4-hydroxytryptamine kinase from Psilocybe cubensis

PsiK is a 4-hydroxytryptamine kinase, which catalyses the conversion of 4-hydroxytryptamine to norbaeocystin.

Usage and Biology

The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.

PsiK is a native enzyme obtained from Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin (Fig. 1) and psilocybin (Fig. 2), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool[2].

Fig. 1: Phosphorylation of 4-hydroxytryptamine to norbaeocystin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: KEGG
Fig. 2: Phosphorylation of psilocin to psilocybin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: KEGG

Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 397 amino acid polypeptide, with a computed molecular weight of 44.2 kDa.

Fig. 3: pET-28c(+):PsiK plasmid map, showing C-terminal histidine tag, and T7 promoter under the control of the lac operator. Translated peptide is shown as the thin lime green arrow.

A band consistent with expression of PsiK in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).

Fig. 4: Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced E. coli BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.

Activity of PsiK was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiK and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, 4-hydroxytryptamine. The PsiK product, norbaeocystin, was only identified in the sample to which 4-hydroxytryptamine was added, confirming the activity of PsiK in vitro (Fig. 5).

Fig. 5: Mass spectra obtained LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiK and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = PLACEHOLDER with chemical formula PLACEHOLDER was identified, matching PsiK product norbaeocystin.

While norbaeocystin was observed in the sample to which 4-hydroxytryptamine was added (Table 1), it was not observed when 4-hydroxytryptamine was absent (Table 2).

Table 1: Identified compounds in LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiK and pGro7, with the addition of 4-hydroxytryptamine.
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
1.16 0.9 257.0687 C10H14N2O4P norbaeocystin
2.63 20.7 177.1024 C10H13N2O hydroxytryptamine
3.46 2.4 205.0972 C11H13N2O2 tryptophan
10.14 5.1 285.1336 C9H18N8OP unknown
10.14 5.1 285.1336 C14H21O6 unknown
Table 2: Identified compounds in LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiK and pGro7, without the addition of 4-hydroxytryptamine..
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
10.16 11.3 285.1336 C14H21O6 unknown
10.16 11.3 285.1336 C9H18N8OP unknown

In vivo expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 6). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.

Fig. 6: pUS387 plasmid map, showing PsiD, PsiK, and PsiM genes organised in a cluster, driven by a class 1 integron gene cassette Pc promoter, flanked by CuO, a cumate repressor binding operator.
Table 3: Identified compounds in LC/MS of protein extract of E. coli DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine.
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
0.56 23.2 271.0817 C12H15O7 unknown
1.16 12.4 257.0689 C10H14N2O4P norbaeocystin
1.9 0.9 271.0844 C11H16N2O4P baeocystin
2.75 5.2 177.1023 C10H13N2O hydroxytryptamine
5.08 6.4 205.0972 C11H13N2O2 tryptophan
5.82 6.4 161.1074 C10H13N2 tryptamine
10.15 14.4 285.1335 C14H21O6 unknown
10.15 14.4 285.1335 C9H18N8OP unknown

The in vivo activity of PsiK is confirmed by observation of PsiK product norbaeocystin (Fig. 7).

Fig. 7: Mass spectra obtained LC/MS of protein extract of E. coli DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 257.06857 with chemical formula C10H14N2O4P was identified, matching PsiK product norbaeocystin.

Given these results, we conclude that we have successfully expressed the 4-hydroxytryptamine kinase decarboxylase PsiK from Psilocybe cubensis in Escherichia coli both in vivo and in vitro.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 864
    Illegal SapI.rc site found at 973


References

  1. Fricke, J., Blei, F. & Hoffmeister, D. Enzymatic Synthesis of Psilocybin. Angew Chem Int Ed Engl 56, 12352-12355 (2017).
  2. Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 40, W597-603 (2012).